Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.51B |
| 2 |
Microsoft
MSFT
|
+$1.13B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.04B |
| 4 |
American Express
AXP
|
+$714M |
| 5 |
HCA Healthcare
HCA
|
+$675M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$6.87B |
| 2 |
Wells Fargo
WFC
|
+$6.1B |
| 3 |
Becton Dickinson
BDX
|
+$3.96B |
| 4 |
Tesla
TSLA
|
+$3.74B |
| 5 |
3M
MMM
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 15.4% |
| 3 | Healthcare | 15.27% |
| 4 | Consumer Discretionary | 11.41% |
| 5 | Communication Services | 10.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KYNB
301
Kyntra Bio
KYNB
$28M
| $546M | 0.06% |
359,249
-315,485
| -47% | -$486M |
|
302
McKesson
MCK
$97.2B
| $546M | 0.06% |
4,112,462
-280,055
| -6% | -$36.5M |
|
|
WMGI
303
DELISTED
Wright Medical Group Inc
WMGI
| $544M | 0.06% |
18,741,152
+2,845,681
| +18% | +$76.7M |
|
304
Trane Technologies
TT
$104B
| $543M | 0.06% |
5,304,443
+838,513
| +19% | +$82M |
|
305
FMC
FMC
$1.32B
| $538M | 0.06% |
7,115,897
+178,423
| +3% | +$13.4M |
|
306
Lam Research
LRCX
$398B
| $537M | 0.06% |
35,381,380
+12,081,490
| +52% | +$206M |
|
307
Starbucks
SBUX
$120B
| $535M | 0.06% |
9,421,005
-1,262,099
| -12% | -$66.7M |
|
308
Murphy Oil
MUR
$5.5B
| $535M | 0.06% |
16,054,989
+186,575
| +1% | +$5.93M |
|
309
Conduent
CNDT
$276M
| $534M | 0.06% |
23,719,861
+1,711,445
| +8% | +$35.1M |
|
310
XPO
XPO
$23.8B
| $534M | 0.06% |
13,521,685
-1,058,560
| -7% | -$38.5M |
|
311
State Street Financial Select Sector SPDR ETF
XLF
$58.5B
| $532M | 0.06% |
19,271,853
-723,631
| -4% | -$20.2M |
|
312
NRG Energy
NRG
$24.7B
| $529M | 0.06% |
14,143,074
+3,032,733
| +27% | +$102M |
|
313
Air Products & Chemicals
APD
$65.6B
| $529M | 0.06% |
3,165,659
-1,291,485
| -29% | -$210M |
|
|
BKI
314
DELISTED
Black Knight, Inc. Common Stock
BKI
| $528M | 0.06% |
10,154,219
+329,311
| +3% | +$17.7M |
|
315
Teva Pharmaceuticals
TEVA
$40.1B
| $527M | 0.06% |
24,481,936
+3,921,785
| +19% | +$91M |
|
316
iShares MSCI EAFE Value ETF
EFV
$29.2B
| $526M | 0.06% |
10,129,514
+6,209,181
| +158% | +$320M |
|
317
Ovintiv
OVV
$16.8B
| $521M | 0.06% |
7,953,802
-442,021
| -5% | -$28.7M |
|
318
Xcel Energy
XEL
$48.6B
| $521M | 0.06% |
11,038,642
-2,688,310
| -20% | -$127M |
|
319
Akamai
AKAM
$17.9B
| $517M | 0.06% |
7,072,798
-481,493
| -6% | -$36.2M |
|
|
BPMC
320
DELISTED
Blueprint Medicines
BPMC
| $514M | 0.06% |
6,583,159
+7,559
| +0.1% | +$525K |
|
|
STOR
321
DELISTED
STORE Capital Corporation
STOR
| $512M | 0.06% |
18,436,821
-3,179,445
| -15% | -$89.5M |
|
322
VF Corp
VFC
$5.99B
| $512M | 0.06% |
5,822,143
+2,141,128
| +58% | +$183M |
|
323
Okta
OKTA
$25.7B
| $511M | 0.06% |
7,269,457
+191,432
| +3% | +$11.4M |
|
324
Vistra
VST
$48.3B
| $511M | 0.06% |
20,528,953
+673,705
| +3% | +$15.5M |
|
325
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.5B
| $508M | 0.06% |
8,161,687
+191,177
| +2% | +$11.9M |
|
Similar funds
Fidelity Investments's Q3 2018 Portfolio in Review
As of Q3 2018, Fidelity Investments held 3,957 positions worth $889B, up 2.3% from $869B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Fidelity Investments withdrew a net $33.9B in Q3 2018, closing 54 positions and reducing 1,318 holdings. Its most notable exit was Williams Partners L.P., an estimated $511M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Fidelity Investments opened a new position in Rubius Therapeutics, Inc worth $141M.
- Fidelity Investments's largest Q3 2018 buy was Rubius Therapeutics, Inc: 6,226,764 shares worth $141M.
- Fidelity Investments added most to Apple in Q3 2018, an estimated $1.51B increase.
- Fidelity Investments's biggest Q3 2018 reduction was Amgen, cutting an estimated $6.87B.
- Fidelity Investments fully exited Williams Partners L.P. in Q3 2018, selling an estimated $511M.
- Fidelity Investments's ten largest holdings make up 22% of its $889B portfolio in Q3 2018.
- Fidelity Investments opened 1,284 new positions and closed 54 in Q3 2018.
- Fidelity Investments's portfolio value rose 2.3% quarter-over-quarter to $889B.
Based on Fidelity Investments's 13F filing for Q3 2018, filed 9 Nov 2018.